• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 16, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

New tech patents could signal disruption for retail eyewear

by rhiannon bowman
August 13, 2020
in Business, Company updates & acquisitions, Local, News, Technology
Reading Time: 2 mins read
A A
Apple isn’t the only company developing wearable technology that could potentially disrupt the eyewear market.

Apple isn’t the only company developing wearable technology that could potentially disrupt the eyewear market.

Share on FacebookShare on Twitter

US tech giant Apple has filed a patent for a new head mounted device (HMD) that it claims can correct vision electronically when the device is worn.

If the device comes to market, a Forbes report notes, the wearer won’t need to see an optometrist for their prescription because it will be detected electronically.

Apple filed the patent in the fourth quarter of 2019 and the United States Patent and Trademark Office published it in June 2020.

The patent covers “a powerful new vision correction optical system that’s able to incorporate a user’s glasses prescription into the system”, according to a patent application report.

The system will then alter the optics to address vision issues such astigmatism, farsightedness, and nearsightedness so that those who wear glasses won’t have to wear them when using Apple’s HMD.

Apple notes that the user input includes a spectacles prescription and the control circuitry is configured to adjust a position of the display with the positioner based on the prescription.

Although the device may not come to market, if the technology is developed, Forbes claims the entire process of getting prescription spectacles in stores will be disrupted.

However, Apple isn’t the only company developing this type of technology. According to the report, a company called Visibly is working with the US Food and Drug Administration for clearance on a process using a computer and a mobile device together to renew a patient’s prescription.

Another company called EyeQue has developed a device to use at home to detect an individual’s prescription and a smartphone app called TESA is in development that will facilitate remote/telemedicine eye examinations.

The US eyecare profession is concerned that reducing the need for eyecare visits for prescriptions will prevent the discovery of numerous eye diseases that are currently detected by early tests during prescription eye examinations.

Apple also filed a patent application in the second quarter of 2019, which was published by the US Patent Office in January 2020.

That patent relates to a future mixed reality headset that will allow those with prescription glasses to put their unique lenses into a headset to eliminate the need to wear exterior glasses in the headset making it bulkier and less comfortable.

Tags: AppleForbeshead mounted devicepatentprescriptionvision correctionwearable technology

Related Posts

The optometry school is proposed for James Cook University. Image: EQRoy/Shutterstock.com.

New Queensland optometry school under consideration despite opposition

by Myles Hume
July 16, 2025

A new optometry school – which would be Australia’s eighth – is being proposed in North Queensland, as debate about...

The meeting – running for a third time – welcomed a record 560-plus delegates from 37 countries. Image: APSPOS.

APSPOS 2025 recap; dual Brisbane conference success for Think Business Events

by Staff Writer
July 15, 2025

The 3rd Congress of the Asia-Pacific Strabismus and Paediatric Ophthalmology Society (APSPOS), held in Brisbane from 29 June to 1...

Eye tests are just as important for people with diabetes, and KeepSight helps to facilitate these.  Image: Graphicroyalty/stock.adobe.com.

Report: KeepSight helping save vision of 560,000 Aussies

by Staff Writer
July 15, 2025

A newly released report shows that more than 560,000 Australians with diabetes are reducing their risk of blindness by over...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited